• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Friday, August 19, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Pandemic led to profound changes in multiple sclerosis clinical practice

Bioengineer by Bioengineer
April 19, 2021
in Chemistry
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

UC Riverside-led national survey of MS specialists finds nearly 10% had been redeployed to the front lines of COVID-19 patient care

IMAGE

Credit: C. Rosema.

RIVERSIDE, Calif. — A survey of U.S. multiple sclerosis, or MS, specialist clinicians reveals the COVID-19 pandemic has created major changes in how they deliver care.

“Since the pandemic began, more than 95% of our survey respondents reported using telehealth platforms to provide care for their patients,” said Dr. Elizabeth Morrison-Banks, a health sciences clinical professor of neurology in the School of Medicine at the University of California, Riverside, who led the survey reported in the journal Multiple Sclerosis and Related Disorders. “Approximately one half of the respondents were MS specialist neurologists, four out of five of whom indicated that COVID-19 had changed how they were recommending and prescribing MS disease-modifying therapies.”

During the pandemic, the MS specialist neurologists tended to prescribe fewer immunosuppressive agents. Survey respondents also commented on their perceived level of safety and support in the workplace during the pandemic. Most indicated they had access to adequate personal protective equipment, but fewer than 50% reported they had adequate ability to physically distance themselves at work. Nearly 10% of respondents reported they had been redeployed, most commonly to the front lines of COVID-19 care.

“Our findings point to profound changes in MS clinical practice since the onset of the COVID-19 pandemic,” said Morrison-Banks, who directs the Multiple Sclerosis Program at UCR Health. “For better or for worse, when clinical practice patterns change, we should not be surprised to see corresponding changes in patient outcomes.”

Survey respondents included some of the most highly trained MS specialists in the country, considered to be thought leaders for other clinicians in their disciplines.

“Their collective shift, on average, in prescribing fewer of the highest-efficacy immunosuppressive therapies could potentially translate into patients experiencing more MS disease activity,” Morrison-Banks said. “We don’t, however, have enough information yet about COVID-19 outcomes in patients receiving immunosuppressive treatments. We suspect many respondents were decreasing use of certain MS disease-modifying therapies that suppress the immune system — for example, B-cell modulating agents — because they were concerned these agents could trigger severe complications from COVID-19.”

Shortly after the COVID-19 pandemic began, Morrison-Banks attended a virtual MS meeting in which the discussion turned to how MS specialists were responding to the pandemic.

“Sharing our mutual interest in how our colleagues around the country were dealing with the challenges of COVID-19 led to this national survey,” she said. “We did our best to collect and disseminate the survey’s data as early as possible during the COVID-19 pandemic with the hope that the results will be of use to clinicians and people living with MS. Our finding that nearly 10% of survey respondents reported being redeployed because of the viral pandemic led us to consider the extent to which the pandemic has challenged the capacity of the MS health care work force.”

Morrison-Banks stressed that people living with MS need consistent support from their clinicians to ensure they receive the best possible health care.

“We hope people living with MS will not avoid seeing their clinicians because they’re afraid of getting exposed to COVID-19,” she said. “Our survey suggests the vast majority of MS specialists are offering at least some telehealth services so their patients can feel safer as they continue receiving care.”

Next, the team plans to study how clinical practice patterns in MS care will change as more research data are published over the upcoming months, including from ongoing studies exploring how various MS disease-modifying therapies affect outcomes from SARS CoV-2 infection.

###

Morrison-Banks was joined in the research by Katelyn Michtich at the Southern California and Nevada chapter of the National Multiple Sclerosis Society; and Dr. Carrie M. Hersh at the Lou Ruovo Center for Brain Health in Las Vegas.

The research paper is titled “How the COVID-19 Pandemic Has Changed Multiple Sclerosis Clinical Practice: Results of a Nationwide Provider Survey Multiple Sclerosis and Related Disorders.”

The University of California, Riverside (http://www.ucr.edu) is a doctoral research university, a living laboratory for groundbreaking exploration of issues critical to Inland Southern California, the state and communities around the world. Reflecting California’s diverse culture, UCR’s enrollment is more than 25,000 students. The campus opened a medical school in 2013 and has reached the heart of the Coachella Valley by way of the UCR Palm Desert Center. The campus has an annual statewide economic impact of almost $2 billion. To learn more, email [email protected]

Media Contact
Iqbal Pittalwala
[email protected]

Tags: Disabled PersonsHealth Care Systems/ServicesHealth ProfessionalsMedicine/HealthMortality/LongevityMusculatureneurobiologyNeurochemistryPainRehabilitation/Prosthetics/Plastic Surgery
Share12Tweet8Share2ShareShareShare2

Related Posts

Crystal structure of TbMn6Sn6

A breakthrough in magnetic materials research could lead to novel ways to manipulate electron flow with much less energy loss

August 18, 2022
Light in Soybean Canopy

RIPE researchers prove bioengineering better photosynthesis increases yields in food crops for the first time ever

August 18, 2022

Engineers fabricate a chip-free, wireless electronic “skin”

August 18, 2022

Exploring quantum electron highways with laser light

August 18, 2022
Please login to join discussion

POPULAR NEWS

  • Picture of the horse specimen.

    Ancient DNA clarifies the early history of American colonial horses

    57 shares
    Share 23 Tweet 14
  • Fatigue, headache among top lingering symptoms months after COVID

    40 shares
    Share 16 Tweet 10
  • Chi-Huey Wong awarded Tetrahedron Prize for Creativity in Organic Synthesis

    38 shares
    Share 15 Tweet 10
  • Dogs lying in the middle of the road after sunrise at Kewa Pueblo, in no hurry to start the day

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

VaccinesUniversity of WashingtonUrogenital SystemVirologyVehiclesWeather/StormsWeaponryViolence/CriminalsVirusVaccineZoology/Veterinary ScienceUrbanization

Recent Posts

  • Early blood tests predict death, severe disability for traumatic brain injury
  • Obscure gastrointestinal bleeding: rebleeding rates and rebleeding predictors found
  • Collaborations inspired early-career NIH grant that could lead to treatment breakthroughs for a range of medical conditions
  • Novel hypotheses that answer key questions about the evolution of sexual reproduction
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In